Mental health services may be new to the direct-to-consumer telehealth company Hims & Hers (NYSE: HIMS), but those offerings are already shaping up to be an important part of its future, according to co-founder and CEO Andrew Dudum. “We believe this [mental health] specialty to be a foundational pillar of the company in the future, […]
Hims & Hers
Hims & Hers Health (NYSE: HIMS) — a direct-to-consumer telemedicine company — is launching an individual, video-based therapy offering. The new service will complement the platform’s existing mental health portfolio, which includes online psychiatric services, free anonymous support group sessions and a 24/7 phone-based crisis line. The addition fits into the company’s goal to make […]
More than 400 companies across various industries held initial public offerings (IPOs) last year, the most since 2000, even amid the pandemic-led economic downturn. At the same time, many businesses chose to go public by merging with a special purpose acquisition company (SPAC), a maneuver that has gradually gained traction among startups, including the subscription-based […]
When Hims first launched in 2017, the direct-to-consumer telemedicine startup billed itself as a men’s wellness brand focused on providing access to treatment for stigmatized gender-specific conditions such as hair loss and erectile dysfunction. Since then, however, the company has drastically expanded its reach to become a multi-specialty virtual care platform, connecting consumers to licensed […]